'Hopeful' study shows some COVID-19 patients improve with remdesivir

The small observational study followed 61 hospitalised patients who were given the antiviral intravenously

More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with the antiviral remdesivir, an experimental drug being developed by US drug firm Gilead Sciences, according to a study.